Pharmaceutical lobbying in Argentina
: a study of pharmacopolitics

  • Javier Renteria

    Student thesis: Doctoral Thesis


    The main purpose of the research was to examine the process of lobbying in the context of the pharmaceutical industry. It sought to explore "why" and "how" multinational companies carried out pharmaceutical lobbying in Argentina.

    The study aimed to build valid substantive theory that could be used to analyse pharmaceutical lobbying from different perspectives and used corporatism and pluralism to explain the relationship between the pharmaceutical industry and
    government. The application of interest groups formation theory permitted the identification of the pharmaceutical industry as an interest group and the identification of its lobbying style. Lobbying theories based on contribution payments and transmission of information were explored in order to understand the use of these policies in the process of pharmaceutical lobbying. The review of literature on American pharmaceutical lobbying helped in understanding the peculiar instruments and practices present in pharmaceutical lobbying and gave the reader an understanding of the characteristics of this market.

    The research took a phenomenological methodological approach and the research paradigm was post-positivist and constructivist. The researcher followed the grounded theory methodology approach of Strauss and Corbin. The researcher collected data through in-depth semi-structured interviews and participant observation of in-house and external pharmaceutical lobbyists as well as officials.

    The study made several contributions. Firstly, it positioned the pharmaceutical industry as an interest group in the pluralism-corporatism axis as a means to provide a framework for the understanding of its lobbying activities. Secondly, the study defined the lobbying style of the pharmaceutical industry in Argentina compared to lobbying performed in the USA and the EU. Thirdly, it provided a pharmaceutical industry basic lobbying model for Argentina that can be tested in other countries. Finally, it provided a model of cooperative or individual lobbying that stated when it was convenient to build coalitions.
    Date of AwardSept 2006
    Original languageEnglish


    • Lobbying
    • Argentina.
    • Pharmaceutical industry

    Cite this